Caribou Biosciences share price logo

Caribou Biosciences

NASDAQ: CRBU

$0.54

-0.02

(-3.73%)

Live

as on

Caribou Biosciences Stock Performance

as on October 24, 2026 at 6:26 am IST

  • Day's Low

    Day's High

    $0.53
    $0.58
    downward going graph

    1.69%

    Downside

    7.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.44
    $3.54
    downward going graph

    17.92%

    Downside

    555.72%

    Upside

    downward going graph

Caribou Biosciences share price movements today

Previous Close
$0.56
Open
$0.55
Volume
1.4M
Market Cap
$58.4M
Day's Low - High
$0.53 - $0.58
52 Week Low - High
$0.44 - $3.54

Caribou Biosciences Historical Returns

1 Month Return
-56.59 %
3 Month Return
-65.64 %
1 Year Return
-77.6 %
3 Year Return
-85.3 %
5 Year Return
-97.29 %

Caribou Biosciences Stock Fundamentals & Key Indicators

Check Caribou Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$58.4M

EPS (TTM)

-1.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.5

Industry PE ratio

-3.14

PEG Ratio

-0.01

EBITDA

-103.5M

Revenue (TTM)

10.0M

Profit Margin

-129.70%

Return On Equity TTM

-89.11%

Caribou Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Caribou Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Caribou Biosciences image
Caribou Biosciences
Buy$58.4M-97.29%-0.50-129.70%0.00%
Moderna image
Moderna
Neutral$98.1B-37.95%-30.80-12.57%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$44.0BNA27.4787.82%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.9B191.61%30.2886.04%0.00%
Regeneron image
Regeneron
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Caribou Biosciences Stock including INR - Dollar returns

The Caribou Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Caribou Biosciences investment value today

Current value as on today

₹23,323

Returns

-₹76,677

(-76.68%)

Returns from Caribou Biosciences Stock

-₹78,436 (-78.44%)

Dollar Impact

₹1,759 (+1.76%)

Analyst Recommendation on Caribou Biosciences Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for Caribou Biosciences. Average target price of $5.75

Caribou Biosciences Share Price Target

Get share price movements and forecasts by analysts on Caribou Biosciences.

What analysts predicted

90.62%UPSIDE

Target Price

$5.75

Current Price

$0.5391

Analyzed by

2 Analysts

High

$8

Target

$5.75

Low

$8

Caribou Biosciences target price $5.75, a slight upside of 90.62% compared to current price of $0.5391. According to 2 analysts rating.

Indian Investors' Interest in Caribou Biosciences Stock

Search interest for Caribou Biosciences Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:51% versus previous 30 day period

Caribou Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2
3
2
2
2
2
2
3
2
1
Gross Profit
1
2
-27
-27
0
1
-20
3
1
1
Operating Income
-46
-43
-38
-38
-42
-47
-29
-28
-26
-25
EBITDA
-40
-36
-33
-37
-38
-34
-26
-26
-24
-25
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
1
1
1
1
0
0
0
0
Income Before Tax
-41
-37
-34
-35
-39
-54
-27
-27
-25
-24
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-41
-37
-34
-35
-39
-54
-27
-26
-25
-24
Net Profit Margin
70.77%
75.29%
100.00%
-1337.84%
25.92%
51.33%
-919.15%
100.00%
72.92%
100.00%

Caribou Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
12
9
13
34
9
11
Gross Profit
5
-22
8
10
30
6
7
Operating Income
-34
-36
-66
-106
-116
-166
-136
EBITDA
-30
-35
-65
-97
-98
-145
-145
Interest Expense
0
0
0
-
-
-
-
Depreciation
0
0
0
1
3
3
3
Income Before Tax
-30
-36
-66
-99
-101
-149
-148
Income Tax Expense
-7
-1
0
0
0
0
0
Net Income
-23
-34
-66
-99
-102
-149
-148
Net Profit Margin
100.00%
-178.50%
89.75%
73.71%
89.78%
60.71%
67.34%

Caribou Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-41
-37
-34
-35
-39
-54
-27
-26
-25
-24
Operating Cash Flow
-37
-32
-32
-35
-36
-28
-25
-20
-26
-22
Investing Cash Flow
22
21
26
15
49
24
10
17
23
18
Financing Cash Flow
12
0
0
3
0
0
0
4
2
17
Change in Cash
-1
-11
-5
-15
13
-4
-14
1
0
14

Caribou Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-23
-34
-66
-99
-102
-149
-148
Operating Cash Flow
-32
-33
-32
-90
-93
-138
-110
Investing Cash Flow
27
6
-176
-93
-68
86
102
Financing Cash Flow
0
1
433
2
154
16
4
Change in Cash
-4
-25
224
-182
-7
-34
-3

Global Institutional Holdings in Caribou Biosciences

Check out the Institutions with significant holdings in Caribou Biosciences.

Funds
Holdings
Vanguard
4.67%
iShares
3.95%
VANGUARD INDEX FUNDS
3.41%
Selectra Investments
1.33%
Fidelity Concord Street Trust
0.78%
See all

Caribou Biosciences News & Key Events

  • img

    Today's Timeline - 08 October

    Thu, 04:05 PM

    -

    BofA moves Caribou Biosciences to No Rating after strategic review and program discontinuation.

Insights on Caribou Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -54.09M → -24.28M (in $), with an average increase of 27.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CRBU stock has moved up by 19.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 749.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 243.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 3.94M → 1.49M (in $), with an average decrease of 38.3% per quarter

About Caribou Biosciences

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving patients across the United States and internationally. Among its primary therapeutic candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy currently undergoing Phase 1 clinical trials for relapsed or refractory B cell non-Hodgkin lymphoma, and CB-011, an allogeneic anti-BCMA CAR-T cell therapy targeting relapsed or refractory multiple myeloma. Caribou Biosciences is additionally developing CB-012, an allogeneic anti-CD371 CAR-T cell therapy for relapsed or refractory acute myeloid leukemia, along with CB-020, an allogeneic CAR-NK cell therapy aimed at solid tumors. The company also maintains a collaborative agreement with AbbVie Manufacturing Management Unlimited Company for the joint advancement of CAR-T cell therapies. Founded in 2011, Caribou Biosciences' headquarters are located in Berkeley, California.
OrganisationCaribou Biosciences
Headquarters2929 7th Street, Berkeley, CA, 94710, US
IndustryBiotechnology
CEORachel E. Haurwitz

Key Management of Caribou Biosciences

Name

Title

Dr. Justin Skoble Ph.D.

Senior Vice President of Technical Operations

Ms. Reigin Zawadzki

Chief People Officer

Dr. Tina Albertson M.D., Ph.D.

Chief Medical Officer

Mr. Enrique Zudaire Ph.D.

Senior Vice President of Translational Research

Dr. Rachel E. Haurwitz Ph.D.

Co-Founder, CEO, President & Director

Ms. Barbara G. McClung Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Ryan Fischesser

Interim Principal Accounting Officer & Controller

Mr. Sriram Ryali M.B.A.

Chief Financial Officer

Dr. Jennifer A. Doudna Ph.D.

Co-founder & Member of Scientific Advisory Board

FAQs

What is Caribou Biosciences share price today?

Caribou Biosciences share price today is $0.54 as on . Caribou Biosciences share today touched a day high of $0.58 and a low of $0.53.

What is the 52 week high and 52 week low for Caribou Biosciences share?

Caribou Biosciences share touched a 52 week high of $3.54 on and a 52 week low of $0.44 on . Caribou Biosciences stock price today i.e. is trending at $0.54,which is 84.75% down from its 52 week high and 21.83% up from its 52 week low.

What is Caribou Biosciences's market capitalisation today?

Caribou Biosciences market capitalisation is $0.00T as on .

How to invest in Caribou Biosciences Stock (CRBU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Caribou Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Caribou Biosciences Stock (CRBU) from India?

Indian investors can start investing in Caribou Biosciences (CRBU) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Caribou Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Caribou Biosciences share’s latest price of $0.54 as on October 24, 2026 at 12:56 am IST, you will get 18.5494 shares of Caribou Biosciences. Learn more about fractional shares .

What are the returns that Caribou Biosciences has given to Indian investors in the last 5 years?

Caribou Biosciences stock has given -97.29% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?